Targeting HIF-1 and mTOR expression in hypoxic and normoxic liver cancer cells; towards optimal combination therapy for DEB-TACE.

Activity: Talk or presentation types › Oral presentation

Period19 Sept 2010 → 21 Sept 2010
Event titleCancer and metabolism: Pathways to the Future
Event typeConference
LocationEdinburgh, United KingdomShow on map
Degree of RecognitionInternational